KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Earnings Yield Over TimeFair Value
Percentile Rank17
Studio
Year-over-Year Change

Earnings yield ratio

Latest
-26.83%
↓ 23% vs avg
Percentile
P17
Within normal range
Streak
2 yr
Consecutive growthFair Value
Average
-21.76%
Historical baseline
PeriodValueYoY Change
2025-26.83%+11.5%
2024-30.33%+19.2%
2023-37.55%-42.1%
2022-26.43%-172.5%
2021-9.70%+35.5%
2020-15.04%-150.6%
2019-6.00%+62.3%
2018-15.92%+39.7%
2017-26.42%-12.9%
2016-23.39%-